German company apoQlar announced its plans to raise Series A funding after receiving FDA 510(k) clearance for its VSI HoloMedicine platform, a mixed reality offering that helps surgeons plan for procedures using 3D holographic technology.
The platform enables surgeons to turn radiographic images such as PET, Angio CT, SPECT, CBCT, CT and MRI scans into 3D holograms to examine before surgery....
